Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

A rapid and sensitive assay to identify HLA-DQ2/8 risk alleles for celiac disease using real-time PCR method.

Mashayekhi K, Rostami-Nejad M, Amani D, Rezaei-Tavirani M, Mohaghegh-Shalmani H, Zali MR.

Gastroenterol Hepatol Bed Bench. 2018 Summer;11(3):250-258.

2.

Person centered prediction of survival in population based screening program by an intelligent clinical decision support system.

Safdari R, Maserat E, Asadzadeh Aghdaei H, Javan Amoli AH, Mohaghegh Shalmani H.

Gastroenterol Hepatol Bed Bench. 2017 Winter;10(1):60-65.

3.

Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.

Ehsani Ardakani MJ, Safaei A, Arefi Oskouie A, Haghparast H, Haghazali M, Mohaghegh Shalmani H, Peyvandi H, Naderi N, Zali MR.

Gastroenterol Hepatol Bed Bench. 2016 Dec;9(Suppl1):S14-S22.

4.

The effect of education on the knowledge of patients with celiac disease.

Barzegar F, Rostami-Nejad M, Mohaghegh Shalmani H, Sadeghi A, Allahverdi Khani M, Aldulaimi D.

Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S15-S19.

5.

The Burden of HIV in Iran: Insights from the Global Burden of Disease Study 2010.

Noori A, Rahimzadeh S, Shahbazi M, Moradi G, Saeedi Moghaddam S, Naderimagham S, Mohaghegh Shalmani H, Kompani F, Rezaei N, Shokoohi M.

Arch Iran Med. 2016 May;19(5):329-34. doi: 0161905/AIM.006.

6.

Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.

Mohaghegh Shalmani H, Noori A, Shokoohi M, Khajavi A, Darvishi M, Delavari A, Jamshidi HR, Naderimagham S.

Arch Iran Med. 2015 Aug;18(8):508-14. doi: 015188/AIM.008.

7.

The Helicobacter pylori eradication in the group receiving standard -dose and group continue taking amoxicillin for 4 weeks; a clinical trial study.

Ehsani-Ardakani MJ, Sedaghat M, Eslami G, Mohaghegh Shalmani H.

Gastroenterol Hepatol Bed Bench. 2015 Spring;8(Suppl 1):S54-9.

8.

Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease.

Ehsani Ardakani MJ, Aghajanian M, Nasiri AA, Mohaghegh-Shalmani H, Zojaji H, Maleki I.

Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):151-5.

9.

Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding.

Javad Ehsani Ardakani M, Zare E, Basiri M, Mohaghegh Shalmani H.

Gastroenterol Hepatol Bed Bench. 2013 Fall;6(4):195-201.

10.

Evaluation of the benefit of addition of clidinium C to a Helicobacter pylori eradication regimen.

Chorami M, Zojaji H, Naderi N, Moghimi-Dehkordi B, Mirsattari D, Shalmani HM.

Gastroenterol Hepatol Bed Bench. 2013 Summer;6(3):141-5.

11.

The effects of gluten-free diet on hypertransaminasemia in patients with celiac disease.

Alavi Moghaddam M, Rostami Nejad M, Shalmani HM, Rostami K, Nazemalhosseini Mojarad E, Aldulaimi D, Zali MR.

Int J Prev Med. 2013 Jun;4(6):700-4.

12.

Cholangiocarcinoma: an-eight-year experience in a tertiary-center in Iran.

Mohammad-Alizadeh AH, Ghobakhlou M, Shalmani HM, Zali MR.

Asian Pac J Cancer Prev. 2012;13(11):5381-4.

13.

Evaluation of salivary beta-2 microglobulin as HBV proliferation marker in HBS Ag(+), HBV DNA PCR(+) and HBV DNA PCR(-) subjects.

Abdolsamadi H, Eini P, Ronasi N, Kaboli SA, Hajilooei M, MoghimBeigi A, Davoudi P, AhmadiMotemayel F, Shalmani HM.

Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S105-11.

14.

Polymorphism in two short tandem repeat loci (R-R and S-Q) linked to tRNA genes in Entamoeba dispar isolates.

Nazemalhosseini Mojarad E, Azimirad M, Bayat M, Hellaly A, Aghdaei HA, Shalmani HM.

Gastroenterol Hepatol Bed Bench. 2012 Fall;5(4):202-8.

15.

Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran.

Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR.

Hepat Mon. 2011 Sep;11(9):736-9. doi: 10.5812/kowsar.1735143X.749.

16.

Direct and indirect medical costs of functional constipation: a population-based study.

Mohaghegh Shalmani H, Soori H, Khoshkrood Mansoori B, Vahedi M, Moghimi-Dehkordi B, Pourhoseingholi MA, Norouzinia M, Zali MR.

Int J Colorectal Dis. 2011 Apr;26(4):515-22. doi: 10.1007/s00384-010-1077-4. Epub 2010 Oct 19.

PMID:
20957375
17.

Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.

Minakari M, Molaei M, Shalmani HM, Mohammad Alizadeh AH, Jazi AH, Naderi N, Shavakhi A, Mashayekhi R, Zali MR.

Eur J Gastroenterol Hepatol. 2009 May;21(5):512-6. doi: 10.1097/MEG.0b013e328326792e.

PMID:
19190500
18.

Helicobacter pylori infection and expression of DNA mismatch repair proteins.

Mirzaee V, Molaei M, Shalmani HM, Zali MR.

World J Gastroenterol. 2008 Nov 21;14(43):6717-21.

19.

Hepatic steatosis in Iranian patients with chronic hepatitis C.

Minakari M, Sameni FK, Shalmani HM, Molaee M, Zali MR.

Med Princ Pract. 2008;17(2):126-30. doi: 10.1159/000112966. Epub 2008 Feb 19.

20.

A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.

Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M.

Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1075-81.

PMID:
17998832

Supplemental Content

Loading ...
Support Center